Issue 1/2018
Content (14 Articles)
Volumetric modulated arc therapy (VMAT) to deliver nodal irradiation in breast cancer patients
Giuseppe Carlo Iorio, Pierfrancesco Franco, Elena Gallio, Stefania Martini, Francesca Arcadipane, Sara Bartoncini, Nadia Rondi, Francesca Romana Giglioli, Ada Ala, Mario Airoldi, Michela Donadio, Corrado De Sanctis, Isabella Castellano, Umberto Ricardi
Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
Joanna Rupa-Matysek, Lidia Gil, Maciej Kaźmierczak, Marta Barańska, Mieczysław Komarnicki
Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatment
Gabriela R. Passos, Juliana A. Camargo, Karen L. Ferrari, Mário J. A. Saad, Amilcar C. de Mattos, Leonardo O. Reis
The novel role of IL-37 in prostate cancer: evidence as a promising radiosensitizer
Vivi A. Ding, Ziwen Zhu, Timothy A. Steele, Mark R. Wakefield, Huaping Xiao, Dean Balabanov, Yujiang Fang
Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors
Dorota Ciołczyk-Wierzbicka, Dorota Gil, Piotr Laidler
Large-scale DNA organization is a prognostic marker of breast cancer survival
Martial Guillaud, Qian Ye, Sam Leung, Anita Carraro, Alan Harrison, Malcolm Hayes, Alan Nichol, Mira Keyes
Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy
Nikita Mehra, Prasanth Ganesan, Trivadi S. Ganesan, Surendran Veeriah, Abirami Boopathy, Venkatraman Radhakrishnan, Manikandan Dhanushkodi, Swaminathan Rajaraman, Sevaluxmy Ganesharajah, Tenali Gnana Sagar
Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study
Katarzyna Mizia-Stec, Marek Elżbieciak, Maciej T. Wybraniec, Monika Różewicz, Artur Bodys, Wojciech Braksator, Zbigniew Gąsior, Piotr Gościniak, Tomasz Hryniewiecki, Jarosław Kasprzak, Andrzej Wojtarowicz, Barbara Zdziarska, Edyta Płońska-Gościniak
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications
Biagio Ricciuti, Jennifer Foglietta, Rita Chiari, Amirhossein Sahebkar, Maciej Banach, Vanessa Bianconi, Matteo Pirro
IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes
Alessandro Del Gobbo, Annamaria Morotti, Anna Eleonora Colombo, Valentina Vaira, Giulia Ercoli, Chiara Pesenti, Eleonora Bonaparte, Elena Guerini-Rocco, Andrea Di Cristofori, Marco Locatelli, Alessandro Palleschi, Stefano Ferrero
More predictive markers were identified for trastuzumab-induced cardiotoxicity
Kadri Altundag
Correction to: Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond
Prasanna Santhanam, Lilja B. Solnes, Steven P. Rowe
Correction to: Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer
Domenico Cante, Edoardo Petrucci, Piera Sciacero, Cristina Piva, Silvia Ferrario, Silvia Bagnera, Sebastiano Patania, Guido Mondini, Massimo Pasquino, Valeria Casanova Borca, Giorgio Vellani, Maria Rosa La Porta, Pierfrancesco Franco